Close this search box.
Close this search box.

Harriet Edwards explores the current landscape for genome editing technologies

Harriet Edwards

An article authored by Harriet Edwards, Associate Director of Regulatory Affairs at Boyds, has been published in Cell & Gene Therapy Insights. In the viewpoint article: ‘2024: the year of the genome editing technologies?’ Harriet looks at the current landscape for genome editing, the regulation surrounding it, and key considerations for regulators and developers as […]

How To De-Risk Your IND Webinar

On March 20, 2024 at 9 am PST, Boyds will host a webinar designed to provide attendees with a plan of action that can help to de-risk your Investigational New Drug (IND) application and expedite the path to gain study clearance.

Meet the Medics

In this new interview series, we sit down and meet the medics at Boyds to find out about their career backgrounds, their interest and passion for medicine, their greatest achievement – whether personal or professional – and get their insights on the latest industry trends.

Double win for Boyds at TOPRA Awards 2023

TOPRA Awards 2023

The TOPRA Awards 2023 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our Senior Director of Regulatory Affairs Katherine Bowen awarded the Inspiration Award. The TOPRA Awards for Regulatory Excellence are the annual international awards for celebrating achievement and best practice in regulatory […]

Boyds grows regulatory affairs team with new hire

We are delighted to announce the appointment of Monica Pianella as Associate Director of Regulatory Affairs. With over seven years’ experience in advanced therapies, Monica joins Boyds from the Cell and Gene Therapy Catapult (CGTC) where she was Senior Regulatory Affairs Manager working in early drug development with a strong focus on CMC and cell […]